Connect Biopharma Holdings (CNTB)

• Market cap: $129M
• 1 day: 2.22%
• 5 days: -4.96%
• 1 month: -10.51%
• 3 months: 42.86%
• 6 months: 130%
• Year to date: 90.08%
• 1 year: 135.63%
• 5 years: -87.56%
• 10 years: -87.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Employees: 62